Living With Polycystic Ovary Syndrome

计划入组 30 人 · 首次发布于 2021 年 3 月 2 日

Berberine and Polycystic Ovary Syndrome

计划入组 12 人 · 首次发布于 2021 年 6 月 18 日

Polycystic Ovary Syndrome and Exercise

计划入组 60 人 · 首次发布于 2017 年 12 月 5 日

Polycystic ovary syndrome(Celmatix)

melatonin receptor agonist (polycystic ovary syndrome)

Metformin(Actoplus Met, Avandamet, Fortamet, Glucophage, Glucovance, Glumetza, Glycon, Invokamet, Janumet, Jentadueto, Kazano, Kombiglyze, Komboglyze, Qternmet, Riomet, Segluromet, Synjardy, Trijardy, Velmetia, Xigduo, Sitagliptin / Metformin hydrochloride Accord, Vildagliptin / Metformin hydrochloride Accord, Vokanamet, Sitagliptin / Metformin hydrochloride Mylan, Efficib, Zomarist, Vipdomet, Sitagliptin / Metformin hydrochloride Sun, Glubrava)

C₄H₁₁N₅ · Rx

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

GLP-1 Receptor Agonists Show Promise in Treating a Range of Conditions Beyond Diabetes and Obesity

PCOS Officially Renamed to PMOS: Landmark Lancet Publication Caps Decade-Long Global Consensus Process

Drug Repurposing Breakthroughs: Established Medications Show Promise in Cancer, Lyme Disease, and Neurological Disorders